Hester Biosciences Ltd.

NSE: HESTERBIO | BSE: 524669 | ISIN: INE782E01017 | Industry: Pharmaceuticals
| Falling Comet
1605.1000 -0.80 (-0.05%)
NSE Dec 12, 2025 15:31 PM
Volume: 3,190
 

1605.10
-0.05%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Standalone revenues grew 20% YoY in H1FY19 to | 80.8 crore on the back of 36% growth in the large animal segment to | 14.8 crore and addition of veterinary social business. The poultry segment grew 10% YoY in H1FY19 to | 62.3 crore EBITDA margins remained healthy at 38% in H1FY19. EBITDA grew 18% YoY in H1FY19 to | 30.5 crore Net profit grew 30% YoY to | 19.6 in H1FY19 crore mainly due to a...
Hester Biosciences Ltd. is trading below all available SMAs
More from Hester Biosciences Ltd.
Recommended